New cancer drug AB801 enters human safety testing

NCT ID NCT06120075

First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This early-stage study is testing a new drug, AB801, alone or with other treatments, in about 91 people with advanced cancers (like lung, colon, or breast cancer) that have not responded to standard therapies. The main goal is to check the drug's safety and find the best dose for future studies. Participants will be closely monitored for side effects and how the drug moves through the body.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast carcinoma cancer colorectal carcinoma head and neck squamous cell carcinoma non-small cell lung carcinoma ovarian carcinoma renal cell carcinoma urinary bladder carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Research Site

    Denver, Colorado, 80218, United States

  • Research Site

    Washington D.C., District of Columbia, 20007, United States

  • Research Site

    Atlanta, Georgia, 30322, United States

  • Research Site

    Grand Rapids, Michigan, 49546, United States

  • Research Site

    New York, New York, 10128, United States

  • Research Site

    Philadelphia, Pennsylvania, 19104, United States

  • Research Site

    Dallas, Texas, 75230, United States

  • Research Site

    San Antonio, Texas, 78229, United States

  • Research Site

    West Valley City, Utah, 84119, United States

  • Research Site

    Fairfax, Virginia, 22031, United States